Biosimilars in IBD: hope or expectation?

Gut. 2013 Jun;62(6):803-7. doi: 10.1136/gutjnl-2012-303824. Epub 2013 Mar 16.
No abstract available

Publication types

  • Review

MeSH terms

  • Biosimilar Pharmaceuticals / adverse effects
  • Biosimilar Pharmaceuticals / chemistry
  • Biosimilar Pharmaceuticals / standards
  • Biosimilar Pharmaceuticals / therapeutic use*
  • Humans
  • Inflammatory Bowel Diseases / drug therapy*
  • Therapeutic Equivalency
  • Treatment Outcome

Substances

  • Biosimilar Pharmaceuticals